Last quarter (Q3 2023), Yield10 Bioscience's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Yield10 Bioscience's net income was $682.00K. See Yield10 Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 147.00K	$ 450.00K	$ 614.00K	$ 799.00K	$ 806.00K	$ 556.00K
Cost of Revenue	$ -151.00K	$ 7.75M	$ 6.20M	-	-	-
Gross Profit	$ 298.00K	$ -7.30M	$ -5.59M	-	-	-
Operating Expense	$ 6.27M	$ 6.15M	$ 6.11M	$ 10.41M	$ 9.40M	$ 9.88M
Operating Income	$ -10.38M	$ -13.45M	$ -11.69M	$ -9.61M	$ -8.60M	$ -9.32M
Net Non Operating Interest Income Expense	-	-	$ 700.00K	$ 0.00	$ -1.25M	$ 158.00K
Other Income Expense	$ -11.00K	$ -41.00K	$ 3.00K	$ -541.00K	$ -3.36M	$ -24.00K
Pretax Income	$ -14.36M	$ -13.41M	$ -10.99M	$ -10.15M	$ -13.21M	$ -9.19M
Tax Provision	$ 129.00K	$ 156.00K	$ 36.00K	$ 56.00K	$ -254.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -10.08M	$ -13.57M	$ -11.03M	$ -10.21M	$ -12.96M	$ -9.19M
Basic EPS	$ -2.48	$ -2.76	$ -2.33	$ -4.30	$ -35.50	$ -36.99
Diluted EPS	$ -2.48	$ -2.76	$ -2.33	$ -4.30	$ -35.50	$ -36.99
Basic Average Shares	$ 24.63M	$ 4.91M	$ 4.73M	$ 2.37M	$ 364.97K	$ 248.31K
Diluted Average Shares	$ 24.63M	$ 4.91M	$ 4.73M	$ 2.37M	$ 364.97K	$ 248.31K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 6.12M	$ 13.90M	$ 12.31M	$ 10.41M	$ 9.40M	$ 9.88M
Net Income From Continuing And Discontinued Operation	$ -14.49M	$ -13.57M	$ -11.03M	$ -10.21M	$ -12.96M	$ -9.19M
Normalized Income	$ -5.85M	-	-	$ -9.75M	$ -9.55M	$ -9.19M
Interest Expense	-	-	-	-	-	-
EBIT	$ -14.36M	$ -13.41M	$ -11.70M	$ -9.61M	$ -8.60M	$ -9.32M
EBITDA	$ -14.08M	$ -13.15M	$ -11.47M	$ -9.43M	$ -8.39M	$ -9.12M

Currency in USD

Yield10 Bioscience Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing